No Pharma Money We do not accept funding from organizations that profit from the development or distribution of prescription drugs.

David Mitchell embraced by President Biden at the White House

News & Reports

The latest from P4ADNow

The latest news, research, policy analysis, and updates from the fight to lower prescription drug prices.

Latest
Explainers
For Press

News Nov 13, 2026

The Week in Review in Prescription Drug Pricing: P4AD CEO to Testify at Senate Judiciary Hearing, ETHIC Momentum Grows, and more

Our CEO Merith Basey will testify at Tuesday’s Senate Judiciary Committee hearing, “Prescribing Sunshine: How Competition & Transparency Lowers Prescription Drug Costs.” The hearing will focus on legislation to address the pharmaceutical industry’s abuse of the patent system — including through patent thickets, pay-for-delay deals, product hopping, and abuse of the citizen petition process.

Read The Full Story

Stay Up To Date

News and reports from P4ADNow

Press Releases May 12, 2025

STATEMENT: P4ADNow Responds To Trump Administration’s ‘Most Favored Nation’ Drug Pricing Announcement

Patients For Affordable Drugs Now Executive Director Merith Basey issued the following statement in response to President Trump’s new Executive Order (EO) on drug pricing:

Read Article News May 9, 2025

This Week in Drug Pricing: Growing Momentum Around International Reference Pricing, P4AD Holds Community Town Hall, Drug Spending Hits Record High As Patients Struggle to Afford Medications, and ICYMI

Senators Josh Hawley (R-MO) and Peter Welch (D-VT) unveiled a bipartisan bill that would bar drug companies from charging Americans more than the international average price for a specific…

Read Article News May 2, 2025

This Week in Drug Pricing: P4AD and AARP Push Back Against Pharma’s EPIC Act, Pharma-Backed Patent Bills Return, Pharma Opposes Tariffs — They Prefer to Hike Prices Themselves, Pharma’s Scapegoat: Inside the $31M Campaign to Shift Blame, and ICYMI

In an exclusive first reported by The Hill, P4ADNow and AARP sent a joint letter to top House committee leaders urging them to reject the EPIC Act (H.R. 1492) — a pharmaceutical industry-backed bill…

Read Article Press Releases May 2, 2025

RELEASE: P4ADNow and AARP Send Letter to Congress Opposing EPIC Act – An Epic Giveaway To Big Pharma That Would Undermine Medicare Negotiation

Patients For Affordable Drugs Now (P4ADNow) and AARP sent a joint letter to key House committee leaders opposing The EPIC Act (H.R. 1492), a bill that would delay when Medicare can negotiate lower…

Read Article Press Releases May 1, 2025

STATEMENT: Patients For Affordable Drugs Now Strongly Opposes Reintroduction of Patent Bills That Protect Pharma Profits Over Patients

Patients For Affordable Drugs Now strongly opposes the reintroduction of two harmful patent bills — the PREVAIL Act and the Patent Eligibility Restoration Act — which would further enable abuse of…

Read Article News Apr 25, 2025

This Week in Drug Pricing: NEW POLL: GOP Voters Overwhelmingly Back Medicare Negotiation, Pharma’s Record-Breaking Lobbying Spend, and ‘Most Favored Nation’ Pricing Floated For 2nd Time

A major new poll from Republican polling firm Fabrizio Ward confirms what patients have long known: Voters overwhelmingly support bold action to lower drug prices, and their views are driven by their lived experiences.

Read Article News Apr 18, 2025

This Week in Drug Pricing: Trump’s Executive Order Includes Massive Pharma Giveaway, Yes, We’re Still Talking About Tariffs, and States Push Back on PBM Power Amid National Reform Debate

President Trump’s new executive order (EO) on drug pricing proposes a sweeping change to the Medicare negotiation program that would delay negotiations for small-molecule drugs, typically lower-cost pills, by four years.

Read Article News Apr 11, 2025

This Week in Drug Pricing: Pharma Tariffs Would Raise Drug Prices, Deepen Patient Struggles, Courts Hear Arguments in Ongoing Lawsuits Against Medicare Negotiation, Medicare Coverage Expansion for Anti-Obesity Drugs Halted and ICYMI

Despite President Trump’s decision to pause broad-based tariffs on most countries, concerns are mounting as he continues to double down on potential pharmaceutical tariffs — a move that would drive…

Read Article News Apr 4, 2025

This Week in Drug Pricing: President Trump, Negotiate A “Better Deal” For Americans, Uncertainty Around Trump Tariffs Raises Concerns for Patients, and ICYMI

P4AD launched a new national TV ad this week, airing on Fox & Friends, urging President Trump to continue defending Medicare’s ability to negotiate lower drug prices and deliver a better deal for American patients.

Read Article News Mar 28, 2025

This Week in Drug Pricing: As Tariffs Loom, Patients Could Pay the Price, Judiciary Committee to Markup Pro-Competition Drug Pricing Bills, AFPI Outlines Drug Pricing Policies in Report, and ICYMI

President Trump confirmed this week that pharmaceutical tariffs remain on the table as part of a broader trade package.

Read Article

Explainers

Drug Pricing Explained

Videos breaking down the policies, practices, and decisions that shape what Americans pay for prescription drugs.

Patient advocate featured in The ETHIC Act Explained

The ETHIC Act Explained: What It Means for Patients

1:49 · Watch on YouTube

How Big Pharma Games the Patent System

3:50 · Watch on YouTube

Dr. Ramachandran discusses delays to Medicare drug price negotiation

Congress Delays Negotiation. Patients Pay the Price.

0:51 · Watch on YouTube

Help us spread the word

Subscribe To Our YouTube

For Press

Patients are available for interviews

Looking for a patient perspective or expert comment? We can connect you with patients, policy experts, and the latest research on prescription drug pricing.

[email protected]

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.